Shanghai Chemspec Corporation (SHA:688602)
China · Delayed Price · Currency is CNY 8.44
-0.03 (-0.35%)
At close: Feb 13, 2026
Shanghai Chemspec Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 725.38 | 653.13 | 951.48 | 1,209 | 967.07 | 599.69 |
Other Revenue | 21.68 | 21.68 | 28.11 | 28.83 | 37.56 | 29.5 |
| 747.06 | 674.81 | 979.59 | 1,238 | 1,005 | 629.2 | |
Revenue Growth (YoY) | 5.42% | -31.11% | -20.89% | 23.25% | 59.67% | -8.45% |
Cost of Revenue | 670.98 | 629.76 | 723.74 | 885.37 | 667.06 | 366.31 |
Gross Profit | 76.08 | 45.06 | 255.85 | 352.83 | 337.57 | 262.89 |
Selling, General & Admin | 94.37 | 98.24 | 95.33 | 98.17 | 83.48 | 111.64 |
Research & Development | 76.42 | 85.39 | 86.86 | 86.78 | 74.96 | 47.24 |
Other Operating Expenses | 1.07 | 2.43 | 5.82 | 8.03 | 8.7 | 5.01 |
Operating Expenses | 169.62 | 189.65 | 186.44 | 191.31 | 167.61 | 164.3 |
Operating Income | -93.54 | -144.59 | 69.41 | 161.52 | 169.97 | 98.58 |
Interest Expense | -5.58 | -7.4 | -9.08 | -6.93 | -9.05 | -8.35 |
Interest & Investment Income | 63.82 | 63.12 | 18.01 | 1.37 | 20.92 | 9.47 |
Earnings From Equity Investments | -37.77 | - | - | 29.72 | - | - |
Currency Exchange Gain (Loss) | 5.03 | 5.03 | 4.75 | -0.14 | -1.91 | -4.07 |
Other Non Operating Income (Expenses) | -0.58 | -0.14 | -0.65 | -0.83 | -0.54 | -7.49 |
EBT Excluding Unusual Items | -68.62 | -83.99 | 82.44 | 184.7 | 179.38 | 88.14 |
Gain (Loss) on Sale of Investments | 3.69 | 8.78 | 4.73 | 4.44 | -41.15 | 3.85 |
Gain (Loss) on Sale of Assets | -1.13 | -0.71 | 25.62 | -2.48 | -0.13 | 0.11 |
Asset Writedown | 12.02 | - | - | - | -2.72 | -1.93 |
Other Unusual Items | 3.16 | 4.11 | 13.02 | 13.81 | 10.16 | 13.54 |
Pretax Income | -50.89 | -71.81 | 125.81 | 200.48 | 147.04 | 103.7 |
Income Tax Expense | -14.07 | -21.15 | 10.68 | 17.79 | 8.75 | 11.1 |
Earnings From Continuing Operations | -36.82 | -50.66 | 115.13 | 182.68 | 138.29 | 92.61 |
Minority Interest in Earnings | 0.68 | 1.12 | -2.43 | -2.12 | -4.22 | -2.33 |
Net Income | -36.14 | -49.53 | 112.7 | 180.56 | 134.07 | 90.28 |
Net Income to Common | -36.14 | -49.53 | 112.7 | 180.56 | 134.07 | 90.28 |
Net Income Growth | - | - | -37.59% | 34.68% | 48.51% | -36.14% |
Shares Outstanding (Basic) | 358 | 495 | 451 | 420 | 388 | 360 |
Shares Outstanding (Diluted) | 358 | 495 | 451 | 420 | 388 | 360 |
Shares Change (YoY) | -35.13% | 9.88% | 7.35% | 8.29% | 7.71% | -0.69% |
EPS (Basic) | -0.10 | -0.10 | 0.25 | 0.43 | 0.35 | 0.25 |
EPS (Diluted) | -0.10 | -0.10 | 0.25 | 0.43 | 0.35 | 0.25 |
EPS Growth | - | - | -41.86% | 24.37% | 38.30% | -35.90% |
Free Cash Flow | -28.13 | -100.83 | 81.41 | 13.19 | -76.08 | -130.72 |
Free Cash Flow Per Share | -0.08 | -0.20 | 0.18 | 0.03 | -0.20 | -0.36 |
Dividend Per Share | - | - | 0.066 | - | - | - |
Gross Margin | 10.18% | 6.68% | 26.12% | 28.49% | 33.60% | 41.78% |
Operating Margin | -12.52% | -21.43% | 7.09% | 13.04% | 16.92% | 15.67% |
Profit Margin | -4.84% | -7.34% | 11.51% | 14.58% | 13.35% | 14.35% |
Free Cash Flow Margin | -3.77% | -14.94% | 8.31% | 1.06% | -7.57% | -20.78% |
EBITDA | 79.78 | 8.7 | 195.99 | 283.08 | 265.28 | 182.61 |
EBITDA Margin | 10.68% | 1.29% | 20.01% | 22.86% | 26.41% | 29.02% |
D&A For EBITDA | 173.32 | 153.29 | 126.58 | 121.57 | 95.31 | 84.03 |
EBIT | -93.54 | -144.59 | 69.41 | 161.52 | 169.97 | 98.58 |
EBIT Margin | -12.52% | -21.43% | 7.09% | 13.04% | 16.92% | 15.67% |
Effective Tax Rate | - | - | 8.49% | 8.88% | 5.95% | 10.70% |
Revenue as Reported | 747.06 | 674.81 | 979.59 | 1,238 | - | - |
Advertising Expenses | - | 0.65 | 0.67 | 0.11 | 0.39 | 0.2 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.